Show simple item record

dc.contributor.authorWiersma, VR
dc.contributor.authorMichalak, M
dc.contributor.authorAbdullah, TM
dc.contributor.authorBremer, E
dc.contributor.authorEggleton, P
dc.date.accessioned2015-09-13T12:23:52Z
dc.date.issued2015-01-29
dc.description.abstractEndoplasmic reticulum (ER) chaperones (e.g., calreticulin, heat shock proteins, and isomerases) perform a multitude of functions within the ER. However, many of these chaperones can translocate to the cytosol and eventually the surface of cells, particularly during ER stress induced by e.g., drugs, UV irradiation, and microbial stimuli. Once on the cell surface or in the extracellular space, the ER chaperones can take on immunogenic characteristics, as mostly described in the context of cancer, appearing as damage-associated molecular patterns recognized by the immune system. How ER chaperones relocate to the cell surface and interact with other intracellular proteins appears to influence whether a tumor cell is targeted for cell death. The relocation of ER proteins to the cell surface can be exploited to target cancer cells for elimination by immune mechanism. Here we evaluate the evidence for the different mechanisms of ER protein translocation and binding to the cell surface and how ER protein translocation can act as a signal for cancer cells to undergo killing by immunogenic cell death and other cell death pathways. The release of chaperones can also exacerbate underlying autoimmune conditions, such as rheumatoid arthritis and multiple sclerosis, and the immunomodulatory role of extracellular chaperones as potential cancer immunotherapies requires cautious monitoring, particularly in cancer patients with underlying autoimmune disease.en_GB
dc.description.sponsorshipCornwall Arthritis Trusten_GB
dc.description.sponsorshipNorthcott Devon Medical Foundationen_GB
dc.description.sponsorshipDutchy Health Charityen_GB
dc.description.sponsorshipHCED Iraq Ph.D. Studentshipen_GB
dc.description.sponsorshipCanadian Institutes of Health Researchen_GB
dc.description.sponsorshipDutch Cancer Societyen_GB
dc.description.sponsorshipNetherlands Organization for Scientific Researchen_GB
dc.identifier.citationVol. 5, Article no. 7en_GB
dc.identifier.doi10.3389/fonc.2015.00007
dc.identifier.urihttp://hdl.handle.net/10871/18212
dc.language.isoenen_GB
dc.publisherFrontiersen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/25688334en_GB
dc.relation.urlhttp://journal.frontiersin.org/article/10.3389/fonc.2015.00007/abstracten_GB
dc.rightsCopyright: © 2015 Wiersma, Michalak, Abdullah, Bremer and Eggleton. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en_GB
dc.subjectER stressen_GB
dc.subjectcalreticulinen_GB
dc.subjectdamage associated molecular patternsen_GB
dc.subjectimmunogenic cell deathen_GB
dc.subjectpost-translational modificationen_GB
dc.titleMechanisms of Translocation of ER Chaperones to the Cell Surface and Immunomodulatory Roles in Cancer and Autoimmunity.en_GB
dc.typeArticleen_GB
dc.date.available2015-09-13T12:23:52Z
dc.identifier.issn2234-943X
exeter.place-of-publicationSwitzerland
dc.descriptionJournal Articleen_GB
dc.descriptionReviewen_GB
dc.descriptionOpen access article originally published in Frontiers in Oncology, 2017, Vol. 5, Article no. 7en_GB
dc.identifier.eissn2234-943X
dc.identifier.journalFrontiers in Oncologyen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record